Patents Assigned to RELEVALE, INC.
  • Publication number: 20250381170
    Abstract: Provided are ergoline derivative containing medicaments disposed within a preassembled, prefilled, single-use delivery device, methods for administering a medicament using a preassembled, prefilled, single-use delivery device, and systems or kits that contain one or more preassembled, prefilled, single-use devices and user instructions, such as for treatment of a migraine or other headache.
    Type: Application
    Filed: August 18, 2025
    Publication date: December 18, 2025
    Applicant: Relevale, Inc.
    Inventors: Ralph Solarski, Robert Edward Malone
  • Patent number: 12414941
    Abstract: Provided are ergoline derivative containing medicaments disposed within a preassembled, prefilled, single-use delivery device, methods for administering a medicament using a preassembled, prefilled, single-use delivery device, and systems or kits that contain one or more preassembled, prefilled, single-use devices and user instructions, such as for treatment of a migraine or other headache.
    Type: Grant
    Filed: November 30, 2022
    Date of Patent: September 16, 2025
    Assignee: Relevale, Inc.
    Inventors: Ralph Solarski, Robert Edward Malone
  • Patent number: 12329749
    Abstract: Provided are ergoline derivative containing medicaments disposed within a preassembled, prefilled, single-use delivery device, methods for administering a medicament using a preassembled, prefilled, single-use delivery device, and systems or kits that contain one or more preassembled, prefilled, single-use devices and user instructions, such as for treatment of a migraine or other headache.
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: June 17, 2025
    Assignee: RELEVALE, INC.
    Inventors: Ralph Solarski, Robert Edward Malone
  • Patent number: 11541043
    Abstract: Provided are ergoline derivative containing medicaments disposed within a preassembled, prefilled, single-use delivery device, methods for administering a medicament using a preassembled, prefilled, single-use delivery device, and systems or kits that contain one or more preassembled, prefilled, single-use devices and user instructions, such as for treatment of a migraine or other headache.
    Type: Grant
    Filed: June 15, 2022
    Date of Patent: January 3, 2023
    Assignee: Relevale, Inc.
    Inventors: Ralph Solarski, Robert Edward Malone
  • Publication number: 20210322392
    Abstract: Provided are ergoline derivative containing medicaments disposed within a preassembled, prefilled, single-use delivery device, methods for administering a medicament using a preassembled, prefilled, single-use delivery device, and systems or kits that contain one or more preassembled, prefilled, single-use devices and user instructions, such as for treatment of a migraine or other headache.
    Type: Application
    Filed: July 1, 2021
    Publication date: October 21, 2021
    Applicant: Relevale, Inc.
    Inventors: Ralph Solarski, Robert Edward Malone
  • Patent number: 11083712
    Abstract: Provided are ergoline derivative containing medicaments disposed within a preassembled, prefilled, single-use delivery device, methods for administering a medicament using a preassembled, prefilled, single-use delivery device, and systems or kits that contain one or more preassembled, prefilled, single-use devices and user instructions, such as for treatment of a migraine or other headache.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: August 10, 2021
    Assignee: RELEVALE, INC.
    Inventors: Ralph Solarski, Robert Edward Malone